Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEW FRONTIER HEALTH CORPORATION

(NFH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo New Frontier Health Corporation
New Frontier Health Corporation is a company principally engaged in the provision of healthcare services. The Company operates private hospitals, outpatient clinics and medical centers. The Company provides preventive care, diagnosis, treatment and rehabilitation services, among others.
Sales per Business
2020
USD (in Million)%
OB/GYN72.0522%
All Other Services49.4515.1%
Family Medicine36.6811.2%
Pediatrics35.7010.9%
Emergency Room31.779.7%
Surgery26.208%
Internal Medicine21.946.7%
Orthopedics20.966.4%
Postpartum Rehabilitation18.015.5%
Dental14.744.5%
Sales per region
20192020Delta
USD (in Million)%USD (in Million)%
China354.45100%327.50100% -7.6%
Managers
NameAgeSinceTitle
Roberta Lipson642019Chief Executive Officer & Executive Director
Carl Wu362020President & Director
Walter Xue522019Chief Financial Officer
Pu Yan Mah, Dr.402021Vice President-Medical Affairs
David Zeng312020Chief Operating Officer & Executive Director
Che-Hung Leong, Dr.802018Independent Director
Kee Loong Chia652020Independent Director
Si Hang Ma682018Independent Director
Harry Chang46-Managing Director
Members of the board
NameAgeSinceTitle
Kam Chung Leung, Dr.682019Co-Chairman
Qi Yu Chen492019Co-Chairman
Carl Wu362020President & Director
Che-Hung Leong, Dr.802018Independent Director
David Zeng312020Chief Operating Officer & Executive Director
Roberta Lipson642019Chief Executive Officer & Executive Director
Shan Fu532019Director
Kee Loong Chia652020Independent Director
Si Hang Ma682018Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 131,356,980 97,599,960 74.3% 0 0.0% 74.3%
Shareholders
NameEquities%
Vivo Capital LLC 14,300,000 9.04%
Capital Research & Management Co. (Global Investors) 12,173,386 7.69%
New Frontier Management GmbH 9,542,500 6.03%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 9,400,000 5.94%
Shanghai Fosun Industry Investment Co., Ltd. 9,400,000 5.94%
Chen Din Hwa Family 9,330,000 5.90%
Capital Research & Management Co. (World Investors) 8,513,186 5.38%
Brave Peak Ltd. 4,875,000 3.08%
Aspex Management (HK) Ltd. 4,081,250 2.58%
Roberta Lipson 3,590,799 2.27%